This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is the Options Market Predicting a Spike in Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tenet Healthcare (THC) stock based on the movements in the options market lately.
HCA Healthcare, Google Cloud Tie Up Amid Coronavirus Woes
by Zacks Equity Research
HCA Healthcare (HCA) partners Google Cloud and SADA for the COVID-19 National Response Portal, a platform to provide real-time COVID-19 updates.
Select Medical Revokes Full-Year View Amid Coronavirus Blues
by Zacks Equity Research
Plagued by business uncertainty from the coronavirus outbreak, Select Medical (SEM) ditches its 2020 earnings guidance.
Tenet Healthcare (THC) Gets Rating Actions From Moody's
by Zacks Equity Research
Tenet Healthcare (THC) gets specific rating actions from credit rating agency Moody's. The outlook of the ratings is stable.
HCA Healthcare Makes Cost-Control Efforts Amid Coronavirus Woes
by Zacks Equity Research
HCA Healthcare (HCA) trims headcount to contain costs as its revenues are under pressure.
Tenet Heathcare Scraps Q1 & 2020 Guidance Amid Coronavirus Chaos
by Zacks Equity Research
Tenet Heathcare (THC) nullifies its first-quarter and 2020 outlook due to the COVID-19 pandemic.
Tenet Healthcare (THC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $13.19 in the latest trading session, marking a +1.38% move from the prior day.
MEDNAX Withdraws Q1 & 2020 Guidance Due to Coronavirus Woes
by Zacks Equity Research
MEDNAX (MD) takes back its first-quarter 2020 and preliminary full-year outlook due to the COVID-19 effect.
Coronavirus-Hit Hospital Stocks Gain on Senate Stimulus Help
by Sapna Bagaria
The stimulus bill will offer the much-required financial relief to COVID-19-plagued hospitals and lead to their share price appreciation.
Why Is Tenet (THC) Down 48.6% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare Cancels U.K. Unit Sale on Coronavirus Crisis
by Zacks Equity Research
Acadia Healthcare (ACHC) dismisses plan to sell its U.K. business due to the economic uncertainty caused by coronavirus outbreak.
Brookdale Scraps Earnings View Due to COVID-19 Uncertainty
by Zacks Equity Research
Brookdale (BKD) pulls down 2020 earnings guidance, takes steps to preserve liquidity and incurs additional cost for prevention measures.
Is Tenet Healthcare (THC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bet on These High Earnings Yield Stocks Amid Coronavirus Scare
by Zacks Equity Research
Check out these five stocks with high earnings yield to power your portfolio.
Tenet Healthcare Down 60.6% YTD: Should You Buy the Dip?
by Zacks Equity Research
Tenet Healthcare (THC) stock down following recommendations to keep elective procedures on hold due to coronavirus outbreak.
Chips Are Down for Hospitals on Coronavirus-Led Business Woes
by Sapna Bagaria
Stocks of hospital companies display a persistent downtrend as they put elective procedures on a back burner to brace up for the fight against a potential spike in coronavirus cases.
Tenet Healthcare (THC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $21.60 in the latest trading session, marking a -1.44% move from the prior day.
Tenet Healthcare Rides on Inorganic Growth, Reduces Leverage
by Zacks Equity Research
Tenet Healthcare (THC) gains traction from strategic initiatives and declining debt load.
Acadia Healthcare Gains From UK Unit Sale, Solid US Business
by Zacks Equity Research
Acadia Healthcare (ACHC) is well poised for growth on several organic and inorganic growth efforts in U.S. business and the ongoing sale proceedings of U.K. operations.
Healthcare Sector to Remain Volatile in 2020 Amid Elections
by Sapna Bagaria
Disparity in the regulatory policies of presidential candidates of various parties renders volatility to the healthcare sector.
Tenet Healthcare (THC) Q4 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) fourth-quarter results reflect improved performance of Ambulatory Care and Hospital segments, offset by poor performance of Conifer segment.
Tenet Healthcare (THC) Q4 Earnings Lag Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of -1.98% and 1.10%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Tenet Healthcare's (THC) Q4 Earnings?
by Zacks Equity Research
Tenet Healthcare's (THC) Q4 results are likely to reflect higher revenues, aided by its Hospital and Other Operations as well as Ambulatory segments, partly offset by lower admissions.
New Strong Buy Stocks for February 20th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
5 High Earnings Yield Stocks to Build a Successful Portfolio
by Zacks Equity Research
While comparing stocks, if other factors are similar, the stock with a higher earnings yield is considered undervalued.